Grants
Summary
Fiscal Year (time period) | Grants name | Issuing authority | Contents/Themes |
---|---|---|---|
FY2015 (Apr. 1/2016-Feb. 28/2017) | FY2015 “Research and Development Venture Support Project / Entrepreneur Candidate (Start-up Innovator)” | New Energy and Industrial Technology Development Organization (NEDO) | Development of cellular medicines using novel human neural stem cells |
FY2018 (Oct. 10/2017-Feb. 28/2018) | FY2018 “Research and Development Venture Support Project / Commercialization Support for R&D Ventures in Seed Phase” | New Energy and Industrial Technology Development Organization (NEDO) | Development of regenerative medicine products using “OligoGenie” human neural stem cells |
FY2019 (Dec. 10/2019-Feb. 9/2020) | FY2019 Project to Promote “Corporate Forest/University-Industry Forest” (Business Promotion Course) | KYOTO Industrial Support Organization 21 | Research and development of GMP production of OligoGenie cells for clinical use |
FY2021 (Jun. 28/2021-Feb. 28/2022) | FY2021 “Startups Solving Social Issues” | Advanced Science, Technology & Management Research Institute of KYOTO (ASTEM) | Establishment of a Master Cell Bank Production Method for Human Neural Stem Cells for Clinical Trials |
FY2021 (Sep. 1/2021-Aug. 31/2022) | FY2021 “Next Generation Regional Industry Promotion Project” | KYOTO Industrial Support Organization 21 | Efficacy of human neural stem cell “OligoGenie” in the treatment of Alzheimer’s disease. |
FY2024 (Oct. 20/2023-Jan. 31/2024) | FY2024 “Small and Medium Enterprise Management Reform Support Project” | KYOTO Industrial Support Organization 21 | Development of oligodendrocyte progenitor cells and culture media for commercial research |
FY2024 (Nov. 27/2023-Sep. 31/2024) | The 13th public offering of “Subsidy for Sustaining Small Businesses” | Central Federation of Societies of Commerce and Industry | Development of exosome formulation for out-licensing to pharmaceutical companies |
FY2025 (Sep. 29/2024-Jan. 31/2025) | FY2025 “Kyoto Economic Gardening Support and Enhancement Project” | KYOTO Industrial Support Organization 21 | Efficacy of Human Neural Stem Cells “OligoGenie” in the Treatment of Multiple Sclerosis |